Patent · US Expired

3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors

US7186716B2 · kind B2 · utility

41Cited by
2References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 12, 2003
Grant dateMar 6, 2007
Priority date—
Expiry dateAug 12, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula I are useful as mediators of protein kinases and have activity as cell proliferation inhibitors:where X, R1–R7 and R9 are as defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.